MMindy finds federal opportunities that fit you, daily.Try free →
Home/Contractors/Ridgeback Biotherapeutics LP

Federal Contractor Profile

Ridgeback Biotherapeutics LP

Federal contracting record: $34M obligated across 2 awards from 1 agencies, FY 20192025.

$34M
Total Obligated
2
Award Records
1
Agencies Served
1
NAICS Codes

Company Profile

Parent UEI (Unique Entity Identifier)

J486UJLMAKB5

CAGE Code

8B1C9

Address

3162 COMMODORE PLAZA STE 3E, MIAMI, FL, 331335815

First Federal Award

Sep 5, 2019

Most Recent Award

Jun 7, 2022

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Health and Human Services

    100.0% of total obligations

    $34M

Top NAICS Activity

  • 541713

    RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY

    2 awards

    $34M

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Apr 19, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541713CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.$1.5M
Oct 29, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541713CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.$3.4M
Aug 14, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541713CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.$1.4M
Feb 4, 2021Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541713CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.$3.0M
Mar 19, 2020Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541713CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.$11M
Sep 5, 2019Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA541713CMC EFFORTS FOR MAB114 DEVELOPMENT FOR THE TREATMENT OF EBOLA.$14M

Related Contractors

Other companies active in NAICS 541713RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY.

Track Ridgeback Biotherapeutics LP Recompetes Before They Post

Mindy monitors Ridgeback Biotherapeutics LP's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts